U.S. markets closed
  • S&P Futures

    3,638.25
    -22.75 (-0.62%)
     
  • Dow Futures

    29,051.00
    -152.00 (-0.52%)
     
  • Nasdaq Futures

    11,236.00
    -97.75 (-0.86%)
     
  • Russell 2000 Futures

    1,658.00
    -10.40 (-0.62%)
     
  • Crude Oil

    77.52
    -0.98 (-1.25%)
     
  • Gold

    1,632.10
    -4.10 (-0.25%)
     
  • Silver

    18.18
    -0.16 (-0.86%)
     
  • EUR/USD

    0.9566
    -0.0032 (-0.33%)
     
  • 10-Yr Bond

    3.9640
    +0.0860 (+2.22%)
     
  • Vix

    32.60
    +0.34 (+1.05%)
     
  • GBP/USD

    1.0661
    -0.0070 (-0.65%)
     
  • USD/JPY

    144.6270
    -0.1640 (-0.11%)
     
  • BTC-USD

    18,731.69
    -1,423.25 (-7.06%)
     
  • CMC Crypto 200

    428.94
    -30.20 (-6.58%)
     
  • FTSE 100

    6,984.59
    -36.36 (-0.52%)
     
  • Nikkei 225

    25,984.51
    -587.36 (-2.21%)
     

PETVIVO HOLDINGS, INC. TO ANNOUNCE RESULTS FOR FIRST QUARTER ENDED JUNE 30, 2022

·2 min read
PetVivo Holdings, Inc.
PetVivo Holdings, Inc.

MINNEAPOLIS, MN, US, Aug. 08, 2022 (GLOBE NEWSWIRE) -- PetVivo Holdings, Inc. (NASDAQ: PETV and PETVW), an emerging biomedical device company focused on the commercialization of innovative medical therapeutics for animals, will report financial results on Thursday, August 11, 2022 after market close. The company will host a conference call to discuss these results at 4:00 p.m. CT (5:00 p.m. ET) on the same day.

Attendees of the live webcast of the conference call and related earnings release materials can register and access the webcast on PetVivo’s Investor Relations website at:

https://audience.mysequire.com/webinar-view?webinar_id=0e18ea79-05ed-4182-b814-7d38937752b5

A replay of the webcast will be available through the same link following the conference call. Participants can also access the call using the dial-in details below.

Date: Thursday, August 11, 2022
Time: 4:00 p.m CT (5:00 pm ET)
Dial-in number: +1 (669) 444-9171
Conference ID: 93383649430
Passcode: 182084

Disclosure Information

PetVivo uses and intends to continue to use its Investor Relations website as a means of disclosing material nonpublic information and for complying with its disclosure obligations under Regulation FD. Accordingly, investors should monitor the company’s Investor Relations website, in addition to following the company’s press releases, SEC filings, public conference calls, presentations and webcasts.

About PetVivo Holdings, Inc.

PetVivo Holdings Inc. (NASDAQ: PETV & PETVW) is an emerging biomedical device company currently focused on the manufacturing, commercialization and licensing of innovative medical devices and therapeutics for companion animals. The Company's strategy is to leverage human therapies for the treatment of companion animals in a capital and time efficient way. A key component of this strategy is the accelerated timeline to revenues for veterinary medical devices, which enter the market much earlier than more stringently regulated pharmaceuticals and biologics.

PetVivo has a pipeline of seventeen products for the treatment of animals and people. A portfolio of nineteen patents protects the Company's biomaterials, products, production processes and methods of use. The Company’s lead product SPRYNG with OsteoCushion technology, a veterinarian-administered, intraarticular injection for the management of lameness and other joint related afflictions, including osteoarthritis, in dogs and horses, is currently available for commercial sale.

For more information about PetVivo Holdings, Inc. and our revolutionary product, Spryng with OsteoCushion Technology, please contact info1@petvivo.com or visit https://petvivo.com/

CONTACT:

John Lai, CEO
PetVivo Holdings, Inc.
Email: info1@petvivo.com
(952) 405-6216